Citation APA
Vincent, J. L., Ramesh, M. K., Ernest, D., LaRosa, S., Pachl, J., Aikawa, N., Hoste, E., Levy, H., Hirman, J., Levi, M., Daga, M., Kutsogiannis, D. J., Crowther, M., Bernard, G., Devriendt, J., Puigserver, J. V., Blanzaco, D. D., Esmon, C. C., Parrillo, J. J., Guzzi, L., Henderson, S. S., Pothirat, C., Mehta, P., Fareed, J., Talwar, D., Tsuruta, K., Osawa, Y., Kaul, I., & Gorelick, K. K. (2013). A randomized, double-blind, placebo-controlled, phase 2b Study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Critical care medicine, 41(9), 2069-2079. doi:10.1097/CCM.0b013e31828e9b03
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/188067